Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Refractory epilepsy]

B Gueguen1

  • 1Service de Neurophysiologie Clinique, Hôpital Sainte-Anne, Paris. gueguen@chsa.broca.inserm.fr

Presse Medicale (Paris, France : 1983)
|January 20, 1999
PubMed
Summary
This summary is machine-generated.

Drug-resistant epilepsy, particularly partial-onset seizures, can be diagnosed after specific treatment trials. Early diagnosis and intervention, including potential surgery, improve patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Sodium Selenite and Selenium-Enriched Spirulina Supplementation Effects After Selenium Deficiency on Growth, Tissue Selenium Concentrations, Antioxidant Activities, and Selenoprotein Expression in Rats.

Biological trace element research·2023
Same author

[Social rehabilitation after epilepsy surgery].

Neuro-Chirurgie·2008
Same author

Motor threshold in transcranial magnetic stimulation: comparison of three estimation methods.

Neurophysiologie clinique = Clinical neurophysiology·2006
Same author

Chess-playing epilepsy: a case report with video-EEG and back averaging.

Epileptic disorders : international epilepsy journal with videotape·2005
Same author

[Indications for EEG in mental confusion and behavior problems].

Neurophysiologie clinique = Clinical neurophysiology·1998
Same author

[Memory disorders in the elderly: complementary examinations--for whom?].

Therapie·1998
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Area of Science:

  • Neurology
  • Epileptology

Context:

  • Partial epilepsies are frequently drug-resistant, contrasting with generalized epilepsies, except for severe childhood syndromes.
  • Diagnosing refractory epilepsy requires a structured approach, not exhaustive trials of all anti-epileptic drugs.
  • Reassessing clinical history and diagnostic methods is crucial for patients with apparent drug resistance.

Purpose:

  • To define criteria for diagnosing drug-resistant epilepsy.
  • To outline mechanisms contributing to treatment resistance.
  • To highlight effective therapeutic strategies, including surgery and new anti-epilepsy drugs.

Summary:

  • Refractory epilepsy is diagnosed if two single-drug regimens and one to two combination regimens with newer drugs fail.
  • Re-evaluation in specialized centers can identify misdiagnosed cases (e.g., non-epileptic events, inadequate treatment).

Related Experiment Videos

  • Video-EEG and ambulatory EEG are valuable diagnostic tools.

    • Impact:

    • Effective and early seizure control significantly impacts prognosis.
    • Surgical intervention for the epileptogenic focus should be considered early.
    • Advances in anti-epilepsy drugs and evidence-based prescribing tailored to epilepsy type and cause are advancing treatment.